Abstract
A critical step in the management of uncontrolled severe asthma—estimated to affect 3–4% of asthma patients (1)—is the identification of the inflammatory phenotype. Severe asthma is a heterogeneous...
Funding Information
  • AstraZeneca

This publication has 55 references indexed in Scilit: